CDC - Antibiotic / Antimicrobial Resistance
Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat patients who have infectious diseases. Since the 1940s, these drugs have greatly reduced illness and death from infectious diseases. Antibiotic use has been beneficial and, when prescribed and taken correctly, their value in patient care is enormous. However, these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. People infected with antimicrobial-resistant organisms are more likely to have longer, more expensive hospital stays, and may be more likely to die as a result of the infection.
Drug Resistance Topics
Transatlantic Task Force on Antimicrobial Resistance (TATFAR)
In response to the mounting threat of antimicrobial resistance (AR), the Transatlantic Taskforce for AR (TATFAR) was established by joint Presidential declaration in 2009 at the annual summit between the European Union (EU) and U.S. presidencies. The 2011 TATFAR Report describing recommendations for collaborations between the U.S. and EU in the fight against the threat of AR can be found here [PDF - 47 pages].
The Interagency Task Force on Antimicrobial Resistance brings together multiple federal agencies to coordinate their efforts in addressing this complex issue